Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-transplantation Bendamustine for GVHD Prophylaxis in Refractory Acute Leukemia
NCT02799147Phase 2Completed
- Sponsor
- First Saint Petersburg State Medical University
- Start
- Jun 2016
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), mixed phenotype acute leukemia (MPAL), sponsored by First Saint Petersburg State Medical University. Started Jun 2016; status: completed.
02
Drugs
bendamustine
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)mixed phenotype acute leukemia (MPAL)
Beyond the preview
Go deeper on NCT02799147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02799147.